Chemoinformaics analysis of MYRICETIN-3-O-RHAMNOSIDE
Molecular Weight | 464.379 | nRot | 3 |
Heavy Atom Molecular Weight | 444.219 | nRig | 24 |
Exact Molecular Weight | 464.095 | nRing | 4 |
Solubility: LogS | -3.971 | nHRing | 2 |
Solubility: LogP | 0.49 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 2 |
nHetero | 12 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 12 | No. of Arom Bond | 17 |
nHA | 12 | APOL | 58.0299 |
nHD | 8 | BPOL | 26.1401 |
QED | 0.244 |
Synth | 4.172 |
Natural Product Likeliness | 2.314 |
NR-PPAR-gamma | 0.962 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.006 |
Pgp-sub | 0.75 |
HIA | 0.716 |
CACO-2 | -6.332 |
MDCK | 0.00000784 |
BBB | 0.006 |
PPB | 0.892335 |
VDSS | 0.891 |
FU | 0.134113 |
CYP1A2-inh | 0.072 |
CYP1A2-sub | 0.061 |
CYP2c19-inh | 0.014 |
CYP2c19-sub | 0.046 |
CYP2c9-inh | 0.027 |
CYP2c9-sub | 0.174 |
CYP2d6-inh | 0.035 |
CYP2d6-sub | 0.159 |
CYP3a4-inh | 0.045 |
CYP3a4-sub | 0.01 |
CL | 4.48 |
T12 | 0.864 |
hERG | 0.062 |
Ames | 0.734 |
ROA | 0.036 |
SkinSen | 0.473 |
Carcinogencity | 0.042 |
EI | 0.082 |
Respiratory | 0.038 |
NR-Aromatase | 0.922 |
Antiviral | Yes |
Prediction | 0.873173 |